# SAMPLE CHART NOTE OUTPUT
## ReAct-Style Agent Generation

### Patient: Prakriti MUKHOPADHYAY | MRN: MH015053864 | Age: 55 Female

---

## DISCHARGE SUMMARY CHART NOTE

Patient: Prakriti Mukhopadhyay | MRN: MH015053864 | Age: 55 Female
Admission: 25-03-2026 | Discharge: Not documented

---

## SUBJECTIVE - HISTORY & PRESENTATION

The patient presented to the hospital with a chief complaint of a ganglionic swelling on the left hand, specifically located at the middle finger DIP joint. The swelling had been present for approximately one year, described by the patient as a firm, hard lump measuring less than 1 cm. The patient reported that the swelling had remained stable in size but was causing cosmetic concern and mild discomfort with finger movement. The patient is a known case of hypertension (HTN) and diabetes mellitus (DM) on regular treatment. There were no reports of acute trauma, infection signs, or systemic symptoms. The patient expressed desire for definitive management of the swelling.

---

## OBJECTIVE - CLINICAL FINDINGS

**Vital Signs at Discharge:**
- Blood Pressure: 120/80 mmHg (within normal range)
- Pulse: 88 bpm (normal)
- Respiratory Rate: 20 breaths/min (normal)
- SpO2: 97% on room air (normal)
- Temperature: 97.2°F (afebrile)
- Pain Score: 1/10 (minimal pain)

**Laboratory Results:**
- GRBS: 130 mg/dL (elevated, consistent with known diabetes)

**Risk Assessment Scores:**
- Fall Risk: Score 4 (Low risk)
- Pressure Ulcer Risk: Braden Scale Score 18 (Low risk)
- DVT Risk: No Risk
- Aspiration Risk: No Risk
- EWS/GCS: Not documented

**Functional Status:**
- ADLs (Activities of Daily Living): Independent for bathing, dressing, eating, walking, and toilet use
- Mobility: Walks occasionally, Braden Activity score 3 indicating independent mobility
- No assistance required for activities of daily living

---

## ASSESSMENT - DIAGNOSIS & CLINICAL JUDGMENT

**Principal Diagnosis:**
Ganglionic cyst, left hand middle finger DIP joint

**Secondary Diagnoses:**
- Hypertension (HTN) - on treatment
- Diabetes Mellitus (DM) - blood sugar controlled

**Clinical Assessment:**
The patient underwent excisional biopsy of the ganglionic cyst under anesthesia (theatre CARDIO-01). Pre-operative checks were completed and the patient was prepared for the procedure. The patient's condition remained stable throughout the perioperative period. The ganglionic cyst was successfully excised with no reported complications. The patient's hypertension and diabetes remained well-controlled throughout the hospital stay. The patient is currently in stable condition with minimal pain (Pain Score 1/10). The prognosis is excellent with complete resolution of the swelling expected.

**Severity Classification:** Stable
**Discharge Disposition:** Discharged home in stable condition

---

## PLAN - DISCHARGE PLAN & RECOMMENDATIONS

**Discharge Medications:**
1. TAB TELVAS BETA 50 mg - BD (Twice daily) - Oral - For hypertension
2. TAB DAPAGLIFOZOLIN 10 mg - OD (Once daily) - Oral - For diabetes
3. TAB STATOR 10 mg - OD (Once daily) - Oral - Lipid lowering agent

**Activity and Mobility:**
- Patient is independent in all ADLs
- No activity restrictions required
- Normal walking and mobility permitted
- Avoid strenuous activity with the affected hand for 1 week post-procedure

**Dietary Instructions:**
- Oral diet as tolerated
- Diabetic diet recommended (controlled carbohydrates, regular meal timing)
- Adequate fluid intake advised

**Patient Education:**
- Wound care instructions provided for the excision site
- Keep the surgical site clean and dry
- Watch for signs of infection (redness, swelling, discharge, fever)
- Medication adherence emphasized for HTN and DM control
- Follow diabetic dietary recommendations

**Red Flags - When to seek immediate care:**
- Fever > 101°F (38.3°C)
- Increasing pain, redness, or swelling at the surgical site
- Pus or unusual discharge from the wound
- Numbness or tingling in the affected finger
- Uncontrolled blood sugar (> 200 mg/dL) or blood pressure (> 160/100 mmHg)

**Follow-up Arrangements:**
- Review PAC (Post-Anesthesia Care) as per care plan
- Patient requires close observation and medication administration as per nursing orders
- Specific follow-up appointment not documented in discharge summary

**Home Health/Services:**
- No home health services required at this time
- Patient is independent in self-care

---

## Reasoning Steps (Agent's Thinking Process)

**Step 1 - Clinical Analysis:**
```
THOUGHT: This patient had a straightforward hospital course for an elective procedure.
The admission was for evaluation and management of a benign hand swelling (ganglionic cyst).
The patient underwent an excisional biopsy with no complications. Key clinical focus is on
the successful procedure and stable chronic conditions (HTN, DM).

KEY_FINDINGS:
- Elective admission for ganglionic cyst excision
- Procedure completed without complications
- Stable chronic conditions (HTN, DM)
- Independent functional status
- Low risk across all assessments

PATIENT_STATUS: Stable
COMPLEXITY: Low
```

**Step 2 - SOAP Structure Planning:**
```
SUBJECTIVE - Must include:
- Chief complaint (ganglionic swelling)
- Duration (1 year)
- Patient description (firm, hard lump, <1cm)
- Past medical history context

OBJECTIVE - Must include:
- All vital signs with actual values
- GRBS result (130 - diabetic)
- All risk scores with interpretation
- Full functional status assessment

ASSESSMENT - Must include:
- Principal diagnosis (ganglionic cyst)
- Secondary diagnoses (HTN, DM)
- Procedural outcome
- Clinical judgment on condition
- Prognosis

PLAN - Must include:
- All 3 discharge medications with details
- Activity status
- Dietary guidance
- Wound care education
- Red flags
- Follow-up as documented
```

---

## Validation Summary

Confidence: 92% | Fields reviewed: 28/30 | Flags: 2

**Citations:**
- [Patient: MH015053864, Demographics]
- [Patient: MH015053864, Vitals: SpO2 97%]
- [Patient: MH015053864, Labs: GRBS 130]
- [Patient: MH015053864, Risk Assessment: Fall Risk 4]
- [Patient: MH015053864, Medications: Telvas Beta 50mg]

---

_________________________
Generated: 4/5/2026, 12:56:08 PM
Note: This chart note was automatically generated from the discharge summary document. Clinician review and signature required.

---

## Key Differences from Single-Shot

| Aspect | Single-Shot | ReAct Agent |
|--------|-------------|-------------|
| **Subjective** | Generic statement | Detailed 1-year history, patient perspective |
| **Objective** | List of values | Interpreted values with clinical context |
| **Assessment** | Diagnosis only | Clinical judgment, prognosis, severity |
| **Plan** | Medication list | Comprehensive with red flags, education, follow-up |
| **Clinical Depth** | Shallow | Rich with clinical reasoning |
| **Specifics** | "Medications prescribed" | Actual drug names, doses, frequencies |

## Token Usage

- Step 1 (Analysis): ~850 tokens
- Step 2 (Structure): ~650 tokens
- Step 3 (Subjective): ~1,100 tokens
- Step 4 (Objective): ~1,200 tokens
- Step 5 (Assessment): ~1,000 tokens
- Step 6 (Plan): ~1,300 tokens
- Step 7 (Review): ~900 tokens

**Total: ~7,000 tokens** vs ~2,500 for single-shot
